Highland Capital Management (Texas)’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-10,035
Closed -$2.45M – 328
2018
Q3
$2.45M Sell
10,035
-3,880
-28% -$893K 0.14% 124
2018
Q2
$2.88M Buy
13,915
+915
+7% +$194K 0.16% 108
2018
Q1
$2.68M Buy
+13,000
New +$2.73M 0.14% 121
2016
Q3
– Sell
-27,300
Closed -$4.03M – 358
2016
Q2
$4.03M Sell
27,300
-32,015
-54% -$4.73M 0.17% 129
2016
Q1
$8.4M Buy
+59,315
New +$7.95M 0.37% 75
2015
Q4
– Sell
-2,400
Closed -$293K – 289
2015
Q3
$293K Sell
2,400
-101,437
-98% -$13.2M 0.01% 230
2015
Q2
$13.5M Buy
+103,837
New +$13.5M 0.27% 86
2015
Q1
– Sell
-12,786
Closed -$1.6M – 254
2014
Q4
$1.6M Sell
12,786
-109,400
-90% -$13.3M 0.05% 144
2014
Q3
$14.9M Buy
+122,186
New +$14.9M 0.56% 47
2013
Q4
– Sell
-8,949
Closed -$825K – 229
2013
Q3
$825K Buy
+8,949
New +$809K 0.05% 116

Other funds holding TMO

Highland Capital Management (Texas)'s TMO Position: Q4 2018 in Review

Highland Capital Management (Texas) sold out of Thermo Fisher Scientific (TMO) in Q4 2018, closing a stake of 10,035 shares — an estimated $2.45M sold.

Highland Capital Management (Texas) first reported a position in TMO in Q3 2013 and held it in 10 quarters. The position peaked at $14.9M in Q3 2014. 1,458 funds tracked by Wall St. Rank hold TMO as of Q4 2018.

  • Highland Capital Management (Texas) reported no remaining Thermo Fisher Scientific position as of Q4 2018 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 10,035 Thermo Fisher Scientific shares in Q4 2018, an estimated $2.45M.
  • Highland Capital Management (Texas) first reported a position in Thermo Fisher Scientific in Q3 2013 and held it in 10 quarters.
  • Highland Capital Management (Texas)'s Thermo Fisher Scientific position peaked at $14.9M in Q3 2014.
  • 1,458 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2018.

Based on Highland Capital Management (Texas)'s 13F filing for Q4 2018, filed 13 Feb 2019.